E-LIB Suche - Ergebnisse für: BECKMANN, K. B.

1

OPTIMAL TAXATION OF BEQUESTS:

BECKMANN, K. B.
Acta Oeconomica. 56 (2006) 2 - p. 167-182 , 2006

Link: https://www.jstor.org/st..

2

Margin status and Survival outcomes following breast conser..:

Bundred, N. ; Bundred, J.R. ; Michael, S....
European Journal of Cancer. 175 (2022) - p. S24 , 2022

Link: https://doi.org/10.1016/..

3

Protocol adherence and outcomes among African/Afro-Caribbea..:

Beckmann, K. ; Aya, H. ; Santa Olalla, A....
European Urology Open Science. 19 (2020) - p. e1917 , 2020

Link: https://doi.org/10.1016/..

4

Is it time to revise active surveillance protocols for men ..:

Beckmann, K. ; Singh, S. ; Sandhu, P....
European Urology Open Science. 19 (2020) - p. e1545 , 2020

Link: https://doi.org/10.1016/..

5

Spironolactone use is associated with lower risk of prostat..:

Beckmann, K. ; Garmo, H. ; Lindahl, B....
European Urology Open Science. 19 (2020) - p. e262 , 2020

Link: https://doi.org/10.1016/..

6

Comparison of different biopsy schedules among men on activ..:

Beckmann, K. ; Bangma, C. ; Hellman, J....
European Urology Open Science. 19 (2020) - p. e1561-e1562 , 2020

Link: https://doi.org/10.1016/..

7

Association between chronic inflammatory diseases, anti-inf..:

Beckmann, K. ; Russell, B. ; Josephs, D....
European Urology Supplements. 18 (2019) 1 - p. e1816 , 2019

Link: https://doi.org/10.1016/..

8

Assessing impact of organised breast screening across small..:

Buckley, E. ; Farshid, G. ; Gill, G....
European Journal of Cancer Care. 26 (2017) 4 - p. e12673 , 2017

Link: https://doi.org/10.1111/..

9

Predictors of Disease Activity in 857 MS Patients Treated w..:

Hartung, H. ; Kappos, L. ; Goodin, D....
Neurology. 78 (2012) Meeting Abstracts 1 - p. PD5.009-PD5.009 , 2012

Link: https://doi.org/10.1212/..

10

Can the functional assessment of multiple sclerosis adapt t..:

Acaster, S ; Swinburn, P ; Wang, C...
Multiple Sclerosis Journal. 17 (2011) 12 - p. 1504-1513 , 2011

Link: https://doi.org/10.1177/..

11

Interferon β-1b and glatiramer acetate effects on permanent..:

Filippi, M. ; Rocca, M.A. ; Camesasca, F....
Neurology. 76 (2011) 14 - p. 1222-1228 , 2011

Link: https://doi.org/10.1212/..

12

Efficacy and safety of a new formulation of CREON® in patie..:

Trapnell, B.C. ; Maguiness, K. ; Graff, G.R....
Journal of Cystic Fibrosis. 8 (2009) - p. S80 , 2009

Link: https://doi.org/10.1016/..

13

ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF ..:

Caloyeras, JP ; Harrow, B ; Wang, C...
Value in Health. 12 (2009) 3 - p. A14 , 2009

Link: https://doi.org/10.1016/..

14

Sample sizes for brain atrophy outcomes in trials for secon..:

Altmann, D. R. ; Jasperse, B. ; Barkhof, F....
Neurology. 72 (2009) 7 - p. 595-601 , 2009

Link: https://doi.org/10.1212/..

15

FP36-WE-06 Evaluation of efficacy, safety and tolerability ..:

Lv, C. ; Zhang, X.H. ; Cui, L.Y....
Journal of the Neurological Sciences. 285 (2009) - p. S115 , 2009

Link: https://doi.org/10.1016/..